基本信息
浏览量:339
职业迁徙
个人简介
My work involves the development of novel therapeutics for malignant primary brain tumors. Our investigations in glioblastoma emphasize the development of imaging and tumor markers of sensitivity and resistance to anti-angiogenic therapeutics in preclinical models and humans. We employ novel MRI and PET imaging techniques in order to define subpopulations of glioblastoma patients most likely to benefit from agents targeting vascular endothelial growth factor (VEGF). We are also involved in defining and exploiting alternative pro-angiogenic targets in order to augment and extend responses to anti-VEGF therapeutics. I am also involved in early phase human trials of targeted therapeutics in molecularly defined subsets of glioblastoma.
I have played central roles in defining the optimal diagnostic and treatment pathways for primary CNS diffuse large B-cell lymphoma (PCNSL). I co-founded the International PCNSL Collaborative Group more than a decade ago and I remain the chair of this organization of over 125 hematologists, neurologists and oncologists from more than 20 countries. In the setting of local, national and international studies we have established the currently recommended diagnostic evaluation for newly diagnosed PCNSL patients. I have also spearheaded key chemotherapy trials for PCNSL contributing to currently recommended treatment guidelines for PCNSL.
研究兴趣
论文共 630 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
RADIOLOGY-ARTIFICIAL INTELLIGENCEno. 1 (2024): e220231-e220231
Blood Advances (2024)
Varun V. Prabhu,Neel S. Madhukar,Coryandar Gilvary,C. Leah B. Kline, Sophie Oster,Wafik S. El-Deiry,Olivier Elemento, Faye Doherty, Alexander VanEngelenburg,Jessica Durrant,Rohinton S. Tarapore,Sean Deacon,
crossref(2023)
Neuro-Oncologyno. Supplement_1 (2023): i50-i50
引用0浏览0引用
0
0
crossref(2023)
crossref(2023)
Neuro-Oncologyno. Supplement_5 (2023): v76-v77
引用0浏览0引用
0
0
openalex(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn